Cargando…

Patient‐reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis

OBJECTIVES: This study aims to describe the use of patient‐reported outcome measures (PROMs) in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) studies and the PROMs landscape. METHODS: A comprehensive literature review was performed in Medline/Embase (since 2000) and ClinicalTrials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stauder, Reinhard, Lambert, Jérémy, Desruol‐Allardin, Sandra, Savre, Isabelle, Gaugler, Lona, Stojkov, Igor, Siebert, Uwe, Chevrou‐Séverac, Hélène
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217037/ https://www.ncbi.nlm.nih.gov/pubmed/31985078 http://dx.doi.org/10.1111/ejh.13389

Ejemplares similares

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2023)

Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group
por: Rochau, Ursula, et al.
Publicado: (2020)

Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project
por: Efficace, Fabio, et al.
Publicado: (2022)

Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists
por: Stojkov, Igor, et al.
Publicado: (2021)

Early enteral nutrition in critical illness: a full economic analysis using US costs
por: Doig, Gordon S, et al.
Publicado: (2013)

The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients
por: Stauder, Reinhard
Publicado: (2012)

Health economics evidence for medical nutrition: are these interventions value for money in integrated care?
por: Walzer, Stefan, et al.
Publicado: (2014)

Health economic analyses in medical nutrition: a systematic literature review
por: Walzer, Stefan, et al.
Publicado: (2014)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Kapoor, Sargam, et al.
Publicado: (2021)

Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study
por: Stojkov, Igor, et al.
Publicado: (2023)

The anemia-independent impact of myelodysplastic syndromes on health-related quality of life
por: Wouters, Hanneke J. C. M., et al.
Publicado: (2021)

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis
por: Langabeer, Stephen E., et al.
Publicado: (2018)

Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2020)

Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Morelli, Emanuela, et al.
Publicado: (2021)

Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
por: Woll, Petter S., et al.
Publicado: (2022)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Abaza, Yasmin, et al.
Publicado: (2022)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Rahmé, Ramy, et al.
Publicado: (2023)

Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costs
por: Mauskopf, Josephine A, et al.
Publicado: (2012)

Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?
por: Adkins, Elizabeth M, et al.
Publicado: (2017)

Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review
por: Olariu, Elena, et al.
Publicado: (2017)

Quality of Life in Wilson’s Disease: A Systematic Literature Review
por: Balijepalli, Chakrapani, et al.
Publicado: (2021)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Familial Myelodysplastic/Acute Leukemia Syndromes—Myeloid Neoplasms with Germline Predisposition
por: Baptista, Renata Lyrio Rafael, et al.
Publicado: (2017)

Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia
por: Shapiro, Roman M., et al.
Publicado: (2018)

Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level
por: Chen, Jiahao, et al.
Publicado: (2018)

Acute Myeloid Leukemia with Basophilic Differentiation Transformed from Myelodysplastic Syndrome
por: Tanaka, Yasuhiro, et al.
Publicado: (2017)

Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Cluzeau, Thomas, et al.
Publicado: (2019)

p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
por: Man, Na, et al.
Publicado: (2021)

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
por: Dutta, Sayantanee, et al.
Publicado: (2022)

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia
por: Yassin, Mohamed A., et al.
Publicado: (2023)

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
por: Ambinder, Alexander J., et al.
Publicado: (2022)

A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia
por: Cantoni, Nathan, et al.
Publicado: (2022)

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK
por: Wilson, Michele R, et al.
Publicado: (2017)

Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting
por: Lang, Katharina M., et al.
Publicado: (2020)

The Epigenetic Landscape of Acute Myeloid Leukemia
por: Conway O'Brien, Emma, et al.
Publicado: (2014)

Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia
por: Wong, Justin J-L, et al.
Publicado: (2014)

Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Dostalova Merkerova, Michaela, et al.
Publicado: (2020)

Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Wong, Kah Keng, et al.
Publicado: (2021)

Gene mutation spectrum of patients with myelodysplastic syndrome and progression to acute myeloid leukemia
por: Liu, Ming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b6ml7t3fkdoko3bapmi5cb3g0u